index	sentence	label
0	@PROTEIN$ enables Ca2+-activated @COMPOUND$-conductance in epithelia.	1
1	Calcium-dependent Cl (-) currents were activated by @COMPOUND$ in HEK293 cells expressing @PROTEIN$.	0
2	Calcium-dependent @COMPOUND$ (-) currents were activated by ATP in HEK293 cells expressing @PROTEIN$.	0
3	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and @PROTEIN$ activation.	1
4	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-@PROTEIN$/FE65 nuclear translocation and GSK3 beta activation.	1
5	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/@PROTEIN$ nuclear translocation and GSK3 beta activation.	1
6	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of @COMPOUND$.	0
7	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of @COMPOUND$), the main constituent of green tea.	0
8	The @PROTEIN$ was purified to homogeneity using ammonium @COMPOUND$ precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
9	The @PROTEIN$ was purified to homogeneity using @COMPOUND$ sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
10	Here we show that during growth in media containing @COMPOUND$ and in complex medium without glucose RamB activates expression of the @PROTEIN$ gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.	0
11	@COMPOUND$ (NAA) is converted into aspartate and acetate by @PROTEIN$.	1
12	N-acetylaspartic acid (NAA) is converted into @COMPOUND$ and acetate by @PROTEIN$.	1
13	N-acetylaspartic acid (NAA) is converted into aspartate and @COMPOUND$ by @PROTEIN$.	1
14	Serum @PROTEIN$ levels were increased and plasma levels of @COMPOUND$ and MHPG were decreased according to the recovery from the active phase of the disease.	0
15	Serum @PROTEIN$ levels were increased and plasma levels of HVA and @COMPOUND$ were decreased according to the recovery from the active phase of the disease.	0
16	These results suggest that dysfunctions of catecholaminergic neurons and @PROTEIN$ might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to @COMPOUND$ might be associated with the improvement of the disease.	0
17	@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
18	Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
19	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
20	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
21	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
22	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
23	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
24	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
25	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, @COMPOUND$, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
26	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, @COMPOUND$, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
27	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and @COMPOUND$ levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
28	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, @COMPOUND$, and albumin levels were observed to be significantly decreased.	0
29	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, @COMPOUND$, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
30	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, @COMPOUND$, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
31	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, @COMPOUND$, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
32	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, @COMPOUND$, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
33	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, @COMPOUND$, and albumin levels were observed to be significantly decreased.	0
34	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and @COMPOUND$ levels were found to be increased; however, beta-carotene, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
35	@PROTEIN$ and glutathione peroxidase antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, @COMPOUND$, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
36	Superoxide dismutase and @PROTEIN$ antioxidant enzyme activities and malondialdehyde levels were found to be increased; however, @COMPOUND$, retinol, vitamin C, vitamin E, reduced glutathione, and albumin levels were observed to be significantly decreased.	0
37	Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, @COMPOUND$, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/nitrogen species.	0
38	Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive @COMPOUND$/nitrogen species.	0
39	Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/@COMPOUND$ species.	0
40	Serum adipocyte @PROTEIN$ levels in patients with type 2 diabetes mellitus and obesity: the influence of @COMPOUND$ treatment.	0
41	Serum @PROTEIN$ levels were 2.5-fold higher in T2DM group relative to C and were not affected by @COMPOUND$ treatment (C: 20.6+/-2.1 microg/l, T2DM before F: 55.6+/-5.7 microg/l, T2DM after F: 54.2+/-5.4 microg/l, p 0.0001 for C vs. T2DM before F).	0
42	FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated @PROTEIN$, atherogenic index and insulin levels.	0
43	@PROTEIN$ levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and insulin levels.	1
44	FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and @PROTEIN$ levels.	0
45	@COMPOUND$ enemas upregulate @PROTEIN$ genes expression but decrease adherent mucus thickness in mice colon.	1
46	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (@PROTEIN$) and membrane-linked (Muc1, Muc3, Muc4) mucins.	1
47	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (Muc2) and membrane-linked (@PROTEIN$, Muc3, Muc4) mucins.	1
48	@COMPOUND$ especially induced a 6-fold increase in @PROTEIN$ gene expression in proximal colon.	1
49	However, @COMPOUND$ enemas did not modify the number of epithelial cells containing the protein @PROTEIN$, and caused a 2-fold decrease in the thickness of adherent mucus layer.	0
50	Short-term withdrawal of @COMPOUND$ induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial @PROTEIN$.	1
51	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
52	Inhibition of LTP by beta-amyloid is prevented by activation of @PROTEIN$ and stimulation of the @COMPOUND$/PKA signalling pathway.	0
53	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig @PROTEIN$ (IL-6) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
54	A novel oligodeoxynuleotides containing 11 @COMPOUND$ motifs was synthesized and inserted into the VR1020 plasmid containing pig interleukin-6 (@PROTEIN$) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	0
55	Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of @COMPOUND$ (LPS) and @PROTEIN$.	0
56	SMC cultured on P(100/0) films modified by covalently attached @PROTEIN$ or fibrin layers proliferated at a rate comparable to that observed on control tissue culture @COMPOUND$.	0
57	However, prewetting P(70/30) with a @COMPOUND$ buffer prior to aminolysis significantly improved cell numbers following immobilization of @PROTEIN$.	0
58	Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1
59	@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
60	Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
61	Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1
62	Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
63	Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
64	No correlation was detected between serum @PROTEIN$ level and @COMPOUND$-25(OH)D3, which was under normal range in 60% of the patients.	0
65	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, @COMPOUND$, Na and FT4.	1
66	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, @COMPOUND$ and FT4.	1
67	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of @COMPOUND$, albumin, Ca, cholesterol, Na and FT4.	1
68	Comparison of 50 patients with the lowest @PROTEIN$ levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both @COMPOUND$ and ICTP between these two populations in spite of the highly significant difference in leptin levels.	0
69	A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (@COMPOUND$), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1
70	A recently discussed cardiovascular risk factor, @COMPOUND$ (ADMA), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1
71	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0
72	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0
73	The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0
74	The non-covalent interaction of @COMPOUND$ (BR) with @PROTEIN$ was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	1
75	Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1
76	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
77	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
78	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
79	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
80	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
81	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
82	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1
83	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1
84	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1
85	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1
86	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
87	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
88	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
89	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and @COMPOUND$.	0
90	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and @COMPOUND$.	0
91	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
92	In-vitro regeneration of @COMPOUND$ inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing xylene linker.	1
93	In-vitro regeneration of sarin inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing @COMPOUND$ linker.	1
94	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, sarin.	0
95	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, @COMPOUND$.	0
96	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, sarin.	0
97	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, @COMPOUND$.	0
98	Among the synthesized compounds, alpha,alpha'xylene-bis-(3,3'-(hydroxyiminomethyl) pyridinium) dibromide (3b) was found to be most potent reactivator for @PROTEIN$ inhibited by @COMPOUND$.	1
99	Of the compounds synthesized, @COMPOUND$, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-@PROTEIN$ with an IC(50) value of 2.81+/-1.26 microM, which is ca.	1
100	Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal @PROTEIN$, as well as decreased @COMPOUND$ sensitivity.	0
101	An individual's response to @COMPOUND$ may be influenced by the amount of @PROTEIN$ (+) and CD8(+) T-lymphocyte suppression.	1
102	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
103	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
104	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of @PROTEIN$ and paxillin in a dose-dependent manner in a Calu-6 xenograft model.	1
105	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and @PROTEIN$ in a dose-dependent manner in a Calu-6 xenograft model.	1
106	Activation of ErbB3, @PROTEIN$ and Erk is essential for growth of human breast cancer cell lines with acquired resistance to @COMPOUND$.	0
107	Treatment with the EGFR inhibitor @COMPOUND$ preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered @PROTEIN$ activation.	0
108	Here, we report that the citrus bioflavonoid @COMPOUND$ reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1
109	Here, we report that the citrus @COMPOUND$ luteolin reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant @PROTEIN$ transgene-bearing neuron-like cells and primary neurons.	1
110	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase @PROTEIN$ processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
111	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote @PROTEIN$ (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
112	We also find that @COMPOUND$ induces changes consistent with GSK-3 inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (@PROTEIN$) carboxyl-terminal fragment (CTF) phosphorylation.	1
113	We also find that @COMPOUND$ induces changes consistent with @PROTEIN$ inhibition that (i) decrease amyloidogenic gamma-secretase APP processing, and (ii) promote presenilin-1 (PS1) carboxyl-terminal fragment (CTF) phosphorylation.	1
114	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts PS1-@PROTEIN$ association.	1
115	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces GSK-3 activity, and disrupts @PROTEIN$-APP association.	1
116	As validation of these findings in vivo, we find that @COMPOUND$, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces @PROTEIN$ activity, and disrupts PS1-APP association.	1
117	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
118	ERK1 and 2 activation stimulated @PROTEIN$ synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
119	@PROTEIN$ and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
120	High resistin levels (50-100 ng/ml) seem able to affect @COMPOUND$-uptake, presumably by decreasing the cell surface @PROTEIN$.	1
121	@COMPOUND$ methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to @PROTEIN$ gene silencing in adenocarcinoma cell lines and can be reversed by 5-aza-2'-deoxycytidine.	1
122	CpG methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to @PROTEIN$ gene silencing in adenocarcinoma cell lines and can be reversed by @COMPOUND$.	1
123	However, increased blood @COMPOUND$ (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for @PROTEIN$.005; 48% for P-selectin, P=NS).	0
124	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and @COMPOUND$ levels remained high.	0
125	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and testosterone levels remained high.	0
126	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and @COMPOUND$ levels remained high.	0
127	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and testosterone levels remained high.	0
128	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight @PROTEIN$ (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	0
129	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra @PROTEIN$ (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	1
130	Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, @COMPOUND$ and aristolochic acid, are able to inhibit @PROTEIN$ (2) from different sources.	1
131	Polyhydroxy phenolic compounds, such as flavonoids, @COMPOUND$, rosmarinic acid and aristolochic acid, are able to inhibit @PROTEIN$ (2) from different sources.	1
132	Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, rosmarinic acid and @COMPOUND$, are able to inhibit @PROTEIN$ (2) from different sources.	1
133	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1
134	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1
135	Although the levels of IL-4, IL-13, IL-10, and @PROTEIN$/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
136	Although the levels of @PROTEIN$, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
137	Although the levels of IL-4, @PROTEIN$, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
138	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and @PROTEIN$ were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
139	Although the levels of IL-4, IL-13, @PROTEIN$, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
140	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, @PROTEIN$ and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	1
141	We hypothesized that variants in @PROTEIN$ that lower LDL @COMPOUND$ levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	1
142	Packed cell volume, total protein, creatinine, blood @COMPOUND$ nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
143	Packed cell volume, total protein, creatinine, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum @COMPOUND$ concentration increased.	0
144	Packed cell volume, total protein, creatinine, blood urea @COMPOUND$, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
145	Packed cell volume, total protein, @COMPOUND$, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
146	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (@PROTEIN$, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
147	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, @PROTEIN$, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
148	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular @PROTEIN$, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
149	The hydrolysis reaction of @COMPOUND$ catalyzed by @PROTEIN$ was followed with in situ UV/vis diode array spectrophotometry.	1
150	Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite NaY, on a @COMPOUND$ support and as cross-linked aggregates.	0
151	Five enzymes-Candida antarctica @PROTEIN$ B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite @COMPOUND$, on a polyacrylate support and as cross-linked aggregates.	0
152	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
153	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
154	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
155	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
156	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated @PROTEIN$ (GHb) in blood.	0
157	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
158	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
159	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
160	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
161	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
162	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
163	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
164	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
165	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
166	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
167	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0
168	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
169	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
170	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
171	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
172	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
173	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
174	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
175	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
176	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
177	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
178	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0
179	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
180	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
181	@PROTEIN$ was decreased with @COMPOUND$ and the coexposure, but not with arsenic, whereas GSH was decreased with arsenic and endosulfan, but not with the coexposure.	1
182	@PROTEIN$ was decreased with endosulfan and the coexposure, but not with arsenic, whereas @COMPOUND$ was decreased with arsenic and endosulfan, but not with the coexposure.	0
183	@PROTEIN$ activity was decreased in the @COMPOUND$-treated and the coexposed birds.	1
184	@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1
185	Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic @COMPOUND$ levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (@PROTEIN$).	0
186	In fact, hepatic @COMPOUND$ levels were significantly increased in the group of mice receiving the probiotic, and the increased @PROTEIN$ expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	1
187	Imatinib is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
188	Imatinib is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
189	@COMPOUND$ is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
190	@COMPOUND$ is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
191	@COMPOUND$ is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
192	Imatinib is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
193	In conclusion, P-gp and @PROTEIN$ have only a modest effect on the ADME of @COMPOUND$ in comparison to metabolic elimination.	1
194	The considerable drug-drug interaction observed with elacridar or @COMPOUND$ is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
195	The considerable drug-drug interaction observed with @COMPOUND$ or pantoprazole is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
196	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, @PROTEIN$-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
197	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of @PROTEIN$-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
198	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, TNF-alpha-, and @PROTEIN$-mRNA in the THP-1 human monocytic cell line.	0
199	Only the @PROTEIN$ of pI 5.4 and superior to 7.6 hydrolyze the @COMPOUND$.	1
200	Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1
201	Decreased hepatic @PROTEIN$ secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with insulin resistance in patients with liver cirrhosis.	1
202	Decreased hepatic RBP4 secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with @PROTEIN$ resistance in patients with liver cirrhosis.	0
203	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (@PROTEIN$/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
204	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of @PROTEIN$ (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
205	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in @PROTEIN$ expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
206	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), @PROTEIN$-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
207	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and @PROTEIN$.	1
208	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/@PROTEIN$), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
209	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of @PROTEIN$ (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
210	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, @PROTEIN$ B1 and c-Myc.	1
211	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of @PROTEIN$, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
212	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and @PROTEIN$, B23).	0
213	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, @PROTEIN$ and nucleophosmin, B23).	0
214	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and nucleophosmin, @PROTEIN$).	0
215	Significant @PROTEIN$ activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in ALP plasticity during acute exposure to @COMPOUND$ point to its possible aplication as an exposure biomarker.	1
216	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (@PROTEIN$).	0
217	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of @PROTEIN$ (17beta-HSD5).	0
218	A role for guanosine 3',5'-cyclic monophosphate (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic @COMPOUND$ release.	0
219	A role for @COMPOUND$ (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0
220	A role for guanosine 3',5'-cyclic monophosphate (@COMPOUND$) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0
221	Application of an inhibitor of soluble guanylate @PROTEIN$ prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-STD elicited in the presence of @COMPOUND$.	0
222	Application of an inhibitor of soluble guanylate cyclase prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-@PROTEIN$ elicited in the presence of @COMPOUND$.	1
223	Distribution of the @PROTEIN$ in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, @COMPOUND$ and corticotrophs.	0
224	A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1
225	A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1
226	Hepatocyte growth factor, keratinocyte growth factor or @PROTEIN$ prevented the effect of @COMPOUND$ on cell permeability, but not on PGE (2) release.	1
227	Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of @COMPOUND$ on cell permeability, but not on @PROTEIN$ (2) release.	0
228	@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
229	Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
230	In all final products, @COMPOUND$ used to prepare the @PROTEIN$/lipid mixture was below 20 ppm.	1
231	@COMPOUND$ up-regulates and activates @PROTEIN$-zeta in EBV-infected and EBV-transformed human B-cells.	1
232	We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
233	We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
234	Postsynaptic action of @COMPOUND$ is mediated through metabotropic P2Y and ionotropic @PROTEIN$ receptors abundantly expressed in neural cells.	1
235	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-@PROTEIN$ N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
236	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (@PROTEIN$)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
237	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like @PROTEIN$ (5 min to 18 h).	1
238	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as @PROTEIN$ (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
239	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased @PROTEIN$ mRNA expression in the jejunum, ileum and colon of VAD rats and increased MUC3 mRNA expression in the ileum and colon of these rats."	1
240	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased MUC2 mRNA expression in the jejunum, ileum and colon of VAD rats and increased @PROTEIN$ mRNA expression in the ileum and colon of these rats."	1
241	In addition, @COMPOUND$ deficiency down-regulated @PROTEIN$ 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	1
242	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
243	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
244	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
245	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
246	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
247	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
248	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
249	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
250	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
251	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
252	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
253	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
254	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
255	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
256	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
257	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
258	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
259	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
260	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
261	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
262	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
263	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
264	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
265	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
266	Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1
267	@COMPOUND$ coatings reduce @PROTEIN$ and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.	1
268	@COMPOUND$ coatings reduce fibrinogen and @PROTEIN$ adsorption and platelet adhesion under both static and flow conditions.	1
269	Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1
270	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
271	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
272	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
273	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
274	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
275	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
276	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
277	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
278	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
279	Differential gene expression of @PROTEIN$ and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with @COMPOUND$.	1
280	The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
281	The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1
282	The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
283	The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and @PROTEIN$ in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
284	The aim of this study was to evaluate the effect of age on the modulation of TLRs and @PROTEIN$ and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
285	The aim of this study was to evaluate the effect of age on the modulation of @PROTEIN$ and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
286	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and @PROTEIN$, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
287	Circulating @PROTEIN$ was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
288	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of @PROTEIN$.	1
289	Circulating leptin was negatively correlated with mRNA expression of adiponectin, @PROTEIN$ and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
290	Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma @COMPOUND$ and advanced glycation end-product concentrations, increased parasympathetic tone, and increased @PROTEIN$ production.	0
291	However, the simultaneous presence of the @PROTEIN$ *1B and CYP3A5 *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
292	However, the simultaneous presence of the CYP3A4 *1B and @PROTEIN$ *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
293	It was found that @COMPOUND$ administration produced lower levels of @PROTEIN$ and alkaline aminotransferase than that of the untreated group.	1
294	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the @COMPOUND$ treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	1
295	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic @COMPOUND$ content exhibited the negative effect.	1
296	In addition, the levels of hepatic total protein, @COMPOUND$ and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	0
297	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
298	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
299	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
300	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
301	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
302	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
303	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
304	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
305	However, TXA(2) formation remains elevated in patients with cardiovascular disease on doses of @COMPOUND$ that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	1
306	However, @COMPOUND$) formation remains elevated in patients with cardiovascular disease on doses of aspirin that fully suppress platelet @PROTEIN$, suggesting other tissue sources for TXA(2) formation.	0
307	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (AVP) and @PROTEIN$ mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
308	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with @COMPOUND$/NBI 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (@PROTEIN$) and CRH mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	0
309	@COMPOUND$ is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits @PROTEIN$ biomarkers in vitro.	1
310	Here we demonstrate that an AR ligand, @COMPOUND$ (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
311	Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (@COMPOUND$), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
312	Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0
313	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of @COMPOUND$ (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	0
314	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of @COMPOUND$ (METH).	1
315	Accumulating evidence suggests that @COMPOUND$ (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	1
316	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1
317	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1
318	However, @COMPOUND$ had no effect on @PROTEIN$ protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.	0
319	However, @COMPOUND$ had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible @PROTEIN$.	0
320	These data indicate that @COMPOUND$ reduces intratesticular activity of @PROTEIN$ (as indicated by PGE (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
321	These data indicate that @COMPOUND$ reduces intratesticular activity of COX-2 (as indicated by @PROTEIN$ (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
322	These results indicate significant roles for products of the @PROTEIN$ pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking @COMPOUND$ for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	1
323	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, @COMPOUND$ esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
324	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of @COMPOUND$, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
325	No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0
326	No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0
327	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
328	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
329	@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1
330	Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of @PROTEIN$ deletion on sustained behavioral responses elicited by repeated @COMPOUND$ administration.	0
331	injection of @PROTEIN$ provoked a significant increase in plasma @COMPOUND$ level.	1
332	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
333	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
334	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
335	We showed that after treatment of HCT116 cells with a low dose of @COMPOUND$ most of them stopped proliferation as documented by SA-@PROTEIN$ activity and the lack of Ki67 expression.	1
336	Tumor @PROTEIN$ differs from normal MUC1 by modified @COMPOUND$ side chains.	0
337	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
338	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
339	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
340	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
341	Metabolism of @COMPOUND$ by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.	1
342	Metabolism of dextrorphan by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of @COMPOUND$ metabolism.	0
343	@PROTEIN$ (CYP2D6) mediated formation of dextrorphan (DOR) from @COMPOUND$ (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
344	@PROTEIN$ (CYP2D6) mediated formation of @COMPOUND$ (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
345	Cytochrome P450 2D6 (@PROTEIN$) mediated formation of @COMPOUND$ (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
346	Cytochrome P450 2D6 (@PROTEIN$) mediated formation of dextrorphan (DOR) from @COMPOUND$ (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
347	@PROTEIN$ (CYP2D6) mediated formation of dextrorphan (@COMPOUND$) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
348	Cytochrome P450 2D6 (@PROTEIN$) mediated formation of dextrorphan (@COMPOUND$) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
349	The sequential metabolism of @COMPOUND$ during in vitro studies, particularly using recombinant systems (rCYPs) expressing human @PROTEIN$, is assumed to be negligible.	0
350	The extent of metabolism was investigated for a range of DEX and @COMPOUND$ concentrations in microsomal preparations from three different rCYPs expressing human @PROTEIN$ (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.	0
351	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of @COMPOUND$ and HYM using ion-trap mass spectrometry.	1
352	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of DOR and @COMPOUND$ using ion-trap mass spectrometry.	1
353	@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1
354	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
355	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
356	@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1
357	@COMPOUND$ significantly decreased gamma-glutamylcysteinyl synthetase and @PROTEIN$ mRNA levels in LLC-PK1 cells.	1
358	Furthermore, @COMPOUND$ also lowered @PROTEIN$ mRNA levels.	1
359	Current data indicate that @COMPOUND$ nephrotoxicity may be, at least partly, mediated by an @PROTEIN$-dependent signal transduction pathway.	1
360	Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific @PROTEIN$ with @COMPOUND$ ; (2) electroporation followed by inhibition of protein synthesis using cycloheximide ; and (3) electroporation only (control).	1
361	Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific @PROTEIN$ with butyrolactone I ; (2) electroporation followed by inhibition of protein synthesis using @COMPOUND$ ; and (3) electroporation only (control).	0
362	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
363	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
364	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
365	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
366	Activities of microbial extracellular enzymes involved in carbon, @COMPOUND$, and phosphorus cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
367	Activities of microbial extracellular enzymes involved in carbon, nitrogen, and @COMPOUND$ cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
368	@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0
369	@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1
370	The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, @COMPOUND$, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0
371	The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and @COMPOUND$) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0
372	The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (@COMPOUND$) microspheres.	0
373	The purpose of this study was to investigate the effect of three zinc salts (i.e., @COMPOUND$, zinc carbonate, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0
374	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
375	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
376	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
377	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
378	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
379	@COMPOUND$ is released from human monocyte-derived macrophages upon stimulation with @PROTEIN$ and is a sensitive indicator for cellular immune activation.	1
380	Both activity and expression of @PROTEIN$ and APS reductase in plants are modulated by the @COMPOUND$ status of the plant.	1
381	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of @COMPOUND$ (ATP) needed for the maintenance of ion gradients across membranes.	1
382	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of adenosine triphosphate (@COMPOUND$) needed for the maintenance of ion gradients across membranes.	1
383	@COMPOUND$ treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (@PROTEIN$) and AKT was markedly increased in vivo.	1
384	In cultured EPC, @COMPOUND$ increased the concentrations of @PROTEIN$, AKT and eNOS.	1
385	In cultured EPC, @COMPOUND$ increased the concentrations of VEGF, AKT and @PROTEIN$.	1
386	Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
387	Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
388	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
389	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
390	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1
391	In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1
392	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1
393	Only the intracellular @PROTEIN$ response in the lower tertile of IL-2 production was improved with @COMPOUND$ indicating a small influence.	1
394	The elevation of @COMPOUND$ plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of @PROTEIN$ in the lower tertile only slightly.	1
395	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on @PROTEIN$ labeled with self-ordered ring of @COMPOUND$.	0
396	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin @PROTEIN$ (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
397	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (@PROTEIN$), @COMPOUND$ (G), respectively.	0
398	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris @PROTEIN$ (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
399	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (@PROTEIN$-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
400	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), @PROTEIN$ (ALP), @COMPOUND$ (G), respectively.	0
401	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (@PROTEIN$), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
402	@COMPOUND$ (NO), which is produced by nitric oxide synthase (@PROTEIN$), may play a role in the development of ASD.	1
403	@COMPOUND$ (NO), which is produced by @PROTEIN$ (NOS), may play a role in the development of ASD.	1
404	Long intercalated defects in canine ribs can be repaired successfully using porous @COMPOUND$ (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone @PROTEIN$-2 (rhBMP-2).	0
405	It has been reported that @COMPOUND$ may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (@PROTEIN$) expression, suggesting that tamoxifen might also retard fibrogenesis.	1
406	Thus, we examined whether @COMPOUND$ might suppress @PROTEIN$ expression and consequently inhibit the process of hepatic fibrosis in vivo.	0
407	Furthermore, 8-bromo-cGMP and @COMPOUND$ failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0
408	Furthermore, @COMPOUND$ and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0
409	@COMPOUND$ decreases expression of osmoprotective genes via direct inhibition of @PROTEIN$ transcriptional activity.	1
410	Because @COMPOUND$ (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and @PROTEIN$ activation in MDCK cells.	0
411	@COMPOUND$, acting on P2X (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (@PROTEIN$), and following prolonged agonist exposure, cell death.	1
412	@COMPOUND$, acting on @PROTEIN$ (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (IL-1beta), and following prolonged agonist exposure, cell death.	1
413	A comparison of the inhibitory effect of @COMPOUND$ on soluble and immobilized @PROTEIN$ showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.	1
414	"The potential action of @COMPOUND$ as a ""chemical chaperone"": increase of @PROTEIN$ activity in fibroblasts from an adult GM1-gangliosidosis patient."	1
415	@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1
416	@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
417	@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
418	Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1
419	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
420	@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1
421	Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1
422	Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1
423	@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1
424	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
425	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
426	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
427	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
428	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
429	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
430	Genetic variants of @PROTEIN$ (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
431	Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (@PROTEIN$) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
432	Genetic variants of cytochrome P450 2C9 (@PROTEIN$) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
433	In conclusion, CYP2C9 and @PROTEIN$ significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1
434	In conclusion, @PROTEIN$ and VKORC1 significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1
435	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
436	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
437	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the ZNF230 promoter contained a functional @PROTEIN$ site.	1
438	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the @PROTEIN$ promoter contained a functional Sp1 site.	1
439	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
440	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
441	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
442	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
443	The anti-hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood @COMPOUND$ (TC) and serum low density lipoprotein (LDL) level, and increase the @PROTEIN$ (HDL) level of the hyperlipemia mice.	0
444	The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (@PROTEIN$), which activate GTPases by catalyzing the exchange of bound @COMPOUND$ for GTP.	1
445	@COMPOUND$ can support the formation of membranous structures and an increase in @PROTEIN$ mRNA levels in differentiating oligodendrocytes.	1
446	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
447	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
448	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
449	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
450	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1
451	@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0
452	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1
453	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
454	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
455	@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
456	@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1
457	Enteric neuronal dopamine (DA) inhibits @COMPOUND$ release and gastric motility; this has been thought to be mediated via neuronal dopamine-2 receptor (@PROTEIN$).	1
458	ATP-gated @PROTEIN$ receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous @COMPOUND$ release.	1
459	However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released @COMPOUND$ acting on presynaptic @PROTEIN$ receptors.	1
460	Unexpectedly, the data suggest @PROTEIN$ receptor activation initiates a form of asynchronous @COMPOUND$ release, rather than detectably affecting the vesicles underlying action potential evoked release.	1
461	The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1
462	SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0
463	@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1
464	SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0
465	A series of @COMPOUND$ derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as @PROTEIN$ and cycloxygenase inhibitory actions.	0
466	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the @COMPOUND$ hallucinogen DOI.	0
467	@PROTEIN$ involvement in the discriminative stimulus effects in rats of @COMPOUND$, but not the phenethylamine hallucinogen DOI.	1
468	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen @COMPOUND$.	0
469	@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1
470	@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0
471	Diastolic function and @PROTEIN$ changes during exercise predict @COMPOUND$ consumption in chronic heart failure patients.	1
472	Like PSC, DSL6A cells secrete less @PROTEIN$ when cultured with @COMPOUND$.	1
473	Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
474	Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
475	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
476	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
477	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and @PROTEIN$ upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
478	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (@PROTEIN$), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
479	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by @PROTEIN$ (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
480	In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1
481	Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to @PROTEIN$, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of @COMPOUND$ to induce angiogenesis.	1
482	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
483	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with estradiol and @COMPOUND$.	1
484	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with @COMPOUND$ and tamoxifen.	1
485	@PROTEIN$-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
486	Tumor necrosis factor-alpha (@PROTEIN$) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
487	Our study indicates that brain @PROTEIN$ activity decreases after @COMPOUND$ administration at doses of 30 mg/kg and 100 mg/kg.	1
488	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
489	The ubiquitous enzyme dUTP nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of @COMPOUND$ into DNA.	0
490	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased @PROTEIN$-induced @COMPOUND$ anion release from macrophages in vivo.	1
491	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (@PROTEIN$) significantly decreased CRP-induced @COMPOUND$ anion release from macrophages in vivo.	0
492	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by @COMPOUND$ and inhibited by tamoxifen.	0
493	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by estradiol and inhibited by @COMPOUND$.	0
494	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
495	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
496	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
497	The experiment also indicated that catalase (@PROTEIN$) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
498	The experiment also indicated that @PROTEIN$ (CAT) activity was not significantly influenced by @COMPOUND$ for both the two tested aquatic plants.	0
499	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1
500	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1
501	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
502	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
503	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
504	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
505	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
506	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1
507	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0
508	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
509	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1
510	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1
511	Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial @PROTEIN$ into LNCaP cells where the tumoricidal effect of 5-fluorouracil (@COMPOUND$) was significantly increased when compared with the cells without the exogenous UPRT.	1
512	Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial @PROTEIN$ into LNCaP cells where the tumoricidal effect of @COMPOUND$ (5-FU) was significantly increased when compared with the cells without the exogenous UPRT.	1
513	We found that the acetylated @PROTEIN$ at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
514	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (@PROTEIN$) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
515	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and @PROTEIN$ (HDAC) 11 expression.	0
516	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the @PROTEIN$ (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
517	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (@PROTEIN$) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
518	The expression of the ERG1, ERG3, ERG7, @PROTEIN$, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
519	The expression of the ERG1, ERG3, ERG7, ERG9, @PROTEIN$ and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
520	The expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and @PROTEIN$ genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
521	The expression of the ERG1, @PROTEIN$, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
522	The expression of the @PROTEIN$, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
523	The expression of the ERG1, ERG3, @PROTEIN$, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
524	Expression of the @PROTEIN$ gene was found to be low or moderate and it was regulated by @COMPOUND$ addition more so than by biofilm formation.	1
525	The expression of the @PROTEIN$ increased in the presence of @COMPOUND$ in some isolates.	1
526	Concentrations of @COMPOUND$ 1000 and Na2SO4 were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
527	Concentrations of polyethylene glycol 1000 and @COMPOUND$ were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
528	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, @PROTEIN$, glutathione peroxidase and glutathione reductase.	1
529	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, glutathione peroxidase and @PROTEIN$.	1
530	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, @PROTEIN$ and glutathione reductase.	1
531	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like @PROTEIN$, catalase, glutathione peroxidase and glutathione reductase.	1
532	L-Carnitine enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) @COMPOUND$ incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	0
533	@COMPOUND$ enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) thymidine incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	1
534	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in @PROTEIN$ (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
535	In our microarray analysis we observed that @PROTEIN$ (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
536	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (@PROTEIN$) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
537	We have generated two novel chimeric @PROTEIN$-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	0
538	We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of @PROTEIN$ fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	1
539	By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1
540	@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1
541	These results suggest that @PROTEIN$ does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive @COMPOUND$ treatment.	0
542	In the present study, we measured plasma @PROTEIN$ levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli @COMPOUND$ per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).	0
543	Furthermore, @PROTEIN$ levels did not correlate with IL-6 levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	1
544	Furthermore, GSTA1-1 levels did not correlate with @PROTEIN$ levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	0
545	Heparin (H), @COMPOUND$ (A), anti@PROTEIN$ III (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
546	Heparin (H), @COMPOUND$ (A), antithrombin III (ATIII), and recombinant human activated @PROTEIN$ (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
547	Heparin (H), @COMPOUND$ (A), antithrombin III (@PROTEIN$), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
548	Heparin (H), @COMPOUND$ (A), @PROTEIN$ (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
549	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
550	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
551	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low @COMPOUND$ (rT3) levels.	1
552	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low 3,3',5'-triiodothyronine (@COMPOUND$) levels.	1
553	Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood @COMPOUND$ and glycated @PROTEIN$ levels.	0
554	In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
555	In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
556	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
557	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
558	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
559	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
560	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (@PROTEIN$ (2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).	0
561	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and cyclooxygenase-2 (@PROTEIN$) expression in bovine synovial fibroblasts (SFs).	0
562	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and @PROTEIN$ (COX-2) expression in bovine synovial fibroblasts (SFs).	0
563	In this study, we compared the effects of @PROTEIN$-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
564	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (@PROTEIN$), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
565	In this study, we compared the effects of insulin-like growth factor-I (@PROTEIN$), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
566	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), @PROTEIN$ (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
567	@COMPOUND$, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (@PROTEIN$) receptor, belongs to the class of aminophthalazines.	1
568	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (@COMPOUND$, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
569	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (@COMPOUND$) have shown significant efficacy in subsets of patients in recent clinical studies.	0
570	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or @COMPOUND$) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
571	@COMPOUND$ was associated with a lower frequency of extrapyramidal symptoms than other antipsychotics, fewer @PROTEIN$-related adverse events than risperidone and other atypical antipsychotics, but greater weight gain than typicals and risperidone.	1
572	In our earlier method, glutathione disulfide (@COMPOUND$) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
573	In our earlier method, @COMPOUND$ (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
574	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of @COMPOUND$.	1
575	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to @COMPOUND$ with @PROTEIN$ (GR) in the presence of NADPH.	1
576	The p-hydroxyphenylpyruvate produced by the Escherichia coli host was converted to @COMPOUND$ through the oxidation reaction of introduced @PROTEIN$.	1
577	The @COMPOUND$ produced by the Escherichia coli host was converted to HGA through the oxidation reaction of introduced @PROTEIN$.	1
578	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
579	Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1
580	Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on @COMPOUND$ with surface-grafted chitosan and immobilized bone @PROTEIN$-2.	0
581	Functional analysis demonstrated that elkj encoded a @PROTEIN$-elongase that mediated the elongation of EPA into @COMPOUND$ (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	1
582	"In the current study, these cells were cultured with three different media: "" @PROTEIN$-plus"" medium containing @COMPOUND$ and 100 ng/mL of rhBMP-2, ""odontogenic"" medium containing dexamethasone, and ""control"" medium without supplements."	0
583	Lecithin:retinol acyltransferase (@PROTEIN$) catalyzes the esterification of retinol (@COMPOUND$).	1
584	@COMPOUND$ (RA) treatment increased this @PROTEIN$ promoter-luciferase activity in PrEC cells, but not in PC-3 cells.	1
585	@COMPOUND$ (RA) treatment increased this LRAT promoter-@PROTEIN$ activity in PrEC cells, but not in PC-3 cells.	1
586	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
587	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
588	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
589	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
590	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
591	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
592	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
593	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
594	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
595	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
596	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
597	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
598	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
599	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
600	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
601	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
602	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
603	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
604	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
605	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
606	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
607	MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0
608	@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1
609	@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1
610	Pretreatment with the MEK-ERK inhibitor (@COMPOUND$) appreciably reversed the mitogenic effects of @PROTEIN$.	1
611	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
612	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
613	Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, @COMPOUND$ (10 microM) appreciably augmented RSVL-evoked cGMP formation, @PROTEIN$ inhibition, and cytostatic response.	1
614	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0
615	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1
616	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and @PROTEIN$ and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
617	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates @PROTEIN$-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
618	@COMPOUND$ causes G(2)/M arrest associated with the modulation of @PROTEIN$ (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
619	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (@PROTEIN$) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
620	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
621	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
622	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
623	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
624	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
625	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
626	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with @PROTEIN$ and cyclin B.	1
627	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in @PROTEIN$ together with cyclin A and cyclin B.	1
628	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of @PROTEIN$ (Cip1), with no change in p27 (Kip1).	1
629	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (@PROTEIN$), with no change in p27 (Kip1).	1
630	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in @PROTEIN$ (Kip1).	0
631	In an additional study, @COMPOUND$ also increased the accumulation of @PROTEIN$ and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).	1
632	The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
633	The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
634	The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
635	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated hemoglobin (HbA1c) and serum @PROTEIN$ were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
636	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated @PROTEIN$ (HbA1c) and serum AGEs were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
637	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
638	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
639	Leptin and soluble @PROTEIN$ receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
640	@PROTEIN$ and soluble leptin receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
641	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
642	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
643	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for glutamine residues the length of which appears to influence @PROTEIN$ (HDL) @COMPOUND$ levels.	1
644	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for @COMPOUND$ residues the length of which appears to influence @PROTEIN$ (HDL) cholesterol levels.	1
645	Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased @PROTEIN$/2 activation following exposure to these drugs.	0
646	Furthermore, restoration of @PROTEIN$ expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased ERK1/2 activation following exposure to these drugs.	1
647	@COMPOUND$ inhibits expression of ADAMTS4 (@PROTEIN$) in human osteoarthritic chondrocytes.	1
648	@COMPOUND$ inhibits expression of @PROTEIN$ (aggrecanase-1) in human osteoarthritic chondrocytes.	1
649	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0
650	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1
651	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0
652	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1
653	Prior to the first dose of @COMPOUND$, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and @PROTEIN$ level with DAS.	0
654	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
655	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, @PROTEIN$, ERG11, ERG24, ERG25 and ERG26.	1
656	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, @PROTEIN$, ERG24, ERG25 and ERG26.	1
657	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including @PROTEIN$, ERG7, ERG11, ERG24, ERG25 and ERG26.	1
658	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, @PROTEIN$ and ERG26.	1
659	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, ERG25 and @PROTEIN$.	1
660	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, @PROTEIN$, ERG25 and ERG26.	1
661	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, @PROTEIN$ on Tregs, and IL-10 production after burns.	1
662	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of CTLA-4, Foxp3 on Tregs, and @PROTEIN$ production after burns.	1
663	Administration of @COMPOUND$ to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of @PROTEIN$, Foxp3 on Tregs, and IL-10 production after burns.	1
664	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
665	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
666	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
667	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
668	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
669	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
670	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
671	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
672	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-D-galactopyranosyl and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-@COMPOUND$ residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
673	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-@COMPOUND$ and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
674	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
675	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
676	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
677	@COMPOUND$ (CPF), a commonly used organophosphorus insecticide, induces @PROTEIN$ inhibition and cholinergic toxicity.	1
678	Role of @PROTEIN$ in apoptosis induced by @COMPOUND$.	1
679	Cholesteryl ester transfer protein (@PROTEIN$) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
680	Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of @PROTEIN$ @COMPOUND$ (HDL-C).	1
681	Cholesteryl ester transfer protein (CETP) is a plasma @PROTEIN$ that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
682	@PROTEIN$ (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
683	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum brain natriuretic peptide levels, and the inflammatory markers C reactive protein and @PROTEIN$, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
684	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum @PROTEIN$ levels, and the inflammatory markers C reactive protein and Interleukin 6, and an improvement in New York Heart Association class, exercise capacity, @COMPOUND$ utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	0
685	In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1
686	@COMPOUND$ inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced @PROTEIN$ phosphorylation and GVBD.	1
687	@COMPOUND$ inhibited MIH induced @PROTEIN$ expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
688	@COMPOUND$ inhibited @PROTEIN$ induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
689	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
690	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
691	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
692	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
693	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
694	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
695	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
696	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
697	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
698	Beta1,4-@PROTEIN$-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
699	Beta1,4-galactosyltransferase-I (@PROTEIN$), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
700	Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-@PROTEIN$, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
701	When compared to the other mammalian @PROTEIN$ genes, the porcine coding sequence contained a single @COMPOUND$ codon inserted into the region encoding the cytoplasmic domain.	1
702	In the absence of @PROTEIN$, cells lost the ability to reduce soluble or insoluble @COMPOUND$).	1
703	DNA sequences of upstream regions of coregulated operons in the adapted mutant are divergent, suggesting the presence of recognition sites for different @PROTEIN$ and indicating that adaptation of the omcB mutant to growth on soluble @COMPOUND$) has shifted the relevant expression networks involved to a more diverse molecular basis.	0
704	@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1
705	In this study, we investigated the molecular mechanism through which @PROTEIN$ is up-regulated by @COMPOUND$ using cultured human neuron-like cells.	1
706	@COMPOUND$, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both @PROTEIN$ messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	1
707	@COMPOUND$ increased transcriptional activity of a human @PROTEIN$ promoter-reporter gene construct.	1
708	ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and @COMPOUND$-induced promoter activities and lowered @PROTEIN$ protein levels.	0
709	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
710	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1
711	These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
712	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
713	Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0
714	With covalent method, @COMPOUND$ was introduced to immobilize @PROTEIN$.	1
715	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein @PROTEIN$.	0
716	Enhancement of @PROTEIN$ expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein HuR.	0
717	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with @PROTEIN$ HuR.	0
718	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein @PROTEIN$.	1
719	Enhancement of @PROTEIN$ expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein HuR.	1
720	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with @PROTEIN$ HuR.	0
721	We have reported previously that @COMPOUND$, a naturally occurring nonmutagenic flavonoid, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	1
722	We have reported previously that apigenin, a naturally occurring nonmutagenic @COMPOUND$, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	0
723	Instead, biosynthetic labeling showed that @COMPOUND$ increased nascent @PROTEIN$ protein synthesis by enhancing p53 translation.	1
724	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein HuR with endogenous @PROTEIN$ mRNA.	1
725	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein @PROTEIN$ with endogenous p53 mRNA.	1
726	Furthermore, @COMPOUND$ treatment increased the level of association of the @PROTEIN$ HuR with endogenous p53 mRNA.	0
727	@COMPOUND$ treatment also augmented @PROTEIN$ translocation into the cytoplasm.	1
728	Overall, these findings indicate that, in addition to modulating @PROTEIN$ protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.	1
729	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein @PROTEIN$.	1
730	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the @PROTEIN$ HuR.	0
731	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (@PROTEIN$), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
732	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; @PROTEIN$/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
733	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), @PROTEIN$ (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
734	Immunoblot analysis of signaling molecules, including cyclic-@PROTEIN$ response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	0
735	@PROTEIN$ resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus @COMPOUND$.	1
736	Aim To investigate retrospectively the impact of @PROTEIN$ resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/@COMPOUND$.	1
737	Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1
738	Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1
739	Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1
740	The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
741	The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
742	The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and @COMPOUND$ to the medium, the level of @PROTEIN$ activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	1
743	Expression was performed in fusion to @COMPOUND$ binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus @PROTEIN$.	0
744	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of @PROTEIN$ (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
745	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and @PROTEIN$ (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
746	@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, @PROTEIN$ and osteocalcin, in a dose-dependent manner in human dermal fibroblasts.	1
747	@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, alkaline phosphatase and @PROTEIN$, in a dose-dependent manner in human dermal fibroblasts.	1
748	Combustion products of @COMPOUND$ inhibit @PROTEIN$ activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.	0
749	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, @COMPOUND$, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.	1
750	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to @COMPOUND$ in combination therapy employing monospecific or bispecific oligos.	0
751	Rat dicarboxylate transporter (@PROTEIN$), expressed in renal tubular epithelial cells, plays a key role in regulating blood and urinary @COMPOUND$ level by reabsorbing citrate from the lumen.	1
752	However, as opposed to exogenous @COMPOUND$, the continuous use of @PROTEIN$ during in vitro differentiation completely blocked rMSC mineralization.	0
753	We show that the effects of both @PROTEIN$-2 and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0
754	We show that the effects of both @PROTEIN$ and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0
755	We show that the effects of both FGF-2 and @COMPOUND$ are mediated through FGF receptor 1 (@PROTEIN$) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	1
756	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
757	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
758	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
759	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
760	@COMPOUND$ stimulates antioxidant response element-mediated expression of @PROTEIN$ in mouse macrophages.	1
761	The current study investigated whether @COMPOUND$ induces transcription of @PROTEIN$ (Gcl), via ARE driven gene expression in mouse macrophages.	0
762	The current study investigated whether @COMPOUND$ induces transcription of glutamate-cysteine ligase (@PROTEIN$), via ARE driven gene expression in mouse macrophages.	0
763	Treatment of mouse macrophages with d-/l-@COMPOUND$ (50microM) induced depletion of intracellular glutathione and a compensatory increase in @PROTEIN$ activity.	1
764	Treatment of mouse macrophages with d-/l-homocysteine (50microM) induced depletion of intracellular @COMPOUND$ and a compensatory increase in @PROTEIN$ activity.	0
765	Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with @COMPOUND$, and this occurred via increased transcription as demonstrated with @PROTEIN$ promoter reporter constructs for Gclc.	0
766	Ligand-induced @PROTEIN$-downregulation modulates cell death associated proteins and enhances chemosensitivity to @COMPOUND$ in THP-1 acute myeloid leukemia cells.	1
767	In sum, @COMPOUND$ exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like @PROTEIN$.	1
768	It was shown that PAR significantly increased serum ALT, @PROTEIN$, ALP, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
769	It was shown that PAR significantly increased serum ALT, AST, @PROTEIN$, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
770	Almost all @PROTEIN$ kinase that translocates to the nucleus shows a marked phosphorylation on @COMPOUND$ 473.	1
771	During the incubation of @COMPOUND$ with para-hydroquinones using @PROTEIN$ as biocatalyst, one or two main products were formed.	1
772	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
773	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
774	To confirm that mouse @PROTEIN$-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by @COMPOUND$ (89).	1
775	For proof of principle, we use L-lactate and @COMPOUND$ as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
776	For proof of principle, we use @COMPOUND$ and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
777	For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced @COMPOUND$.	0
778	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
779	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
780	Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1
781	For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
782	For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
783	Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
784	Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
785	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0
786	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0
787	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
788	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
789	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
790	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
791	The effects of @PROTEIN$ were reversed by the mitochondrial KATP blocker, @COMPOUND$, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	1
792	While bass in all @COMPOUND$ treatment groups had significantly inhibited brain @PROTEIN$ activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	1
793	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by @PROTEIN$ (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
794	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (@PROTEIN$) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
795	The @COMPOUND$ mutation at amino acid location 164 significantly reduced the initial hydrolysis of either the @PROTEIN$ in solution or the proteins bound on HAP, which was confirmed by amelogenin oligopeptide assays.	1
796	In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0
797	In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0
798	Acylation-stimulating protein (@PROTEIN$) has been shown to positively stimulate fatty acid esterification and @COMPOUND$ uptake in adipocytes.	1
799	Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
800	Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
801	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
802	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes @PROTEIN$, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
803	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (@PROTEIN$)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
804	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and @PROTEIN$ while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
805	Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &gt;95% @COMPOUND$ at 7 d indicating a differential expression of @PROTEIN$ products.	1
806	@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1
807	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
808	These results confirm the therapeutic potential of @PROTEIN$ blockade on motor symptoms induced by reduced striatal @COMPOUND$ function.	1
809	Further, they demonstrate that @PROTEIN$ blockade may also have beneficial effects on cognitive deficits induced by @COMPOUND$ depletion.	1
810	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
811	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
812	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
813	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
814	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
815	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
816	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
817	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
818	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
819	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
820	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
821	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
822	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
823	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
824	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
825	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
826	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
827	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
828	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
829	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
830	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
831	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
832	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
833	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
834	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
835	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
836	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
837	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
838	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
839	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
840	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
841	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
842	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
843	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
844	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
845	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
846	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
847	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
848	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
849	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
850	Osteointegration of @COMPOUND$ or its alloy with bone can be greatly improved by calcium phosphate coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	1
851	Osteointegration of titanium or its alloy with bone can be greatly improved by @COMPOUND$ coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	0
852	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
853	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
854	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
855	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
856	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
857	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
858	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with @COMPOUND$ were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
859	Hence, MPTP lesion, @COMPOUND$ treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
860	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and @COMPOUND$, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
861	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1
862	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/@COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
863	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) @COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
864	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and @COMPOUND$.	0
865	or=6 ng/ml) was associated with increased expression of mrp-1 and @PROTEIN$ and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0
866	or=6 ng/ml) was associated with increased expression of mrp-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-@PROTEIN$.	0
867	or=6 ng/ml) was associated with increased expression of @PROTEIN$-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0
868	Furthermore, treatment of @COMPOUND$ and EPA also synergistically blocked the activation of downstream @PROTEIN$ molecule.	1
869	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as @PROTEIN$ and Fas ligand to suppress cell survival.	1
870	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as Bax and @PROTEIN$ to suppress cell survival.	1
871	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1
872	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0
873	Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
874	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
875	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
876	Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
877	Accordingly, the TLR3 agonist @COMPOUND$) (PIC) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1
878	Accordingly, the TLR3 agonist poly(I:C) (@COMPOUND$) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1
879	As siRNA, @COMPOUND$ induced @PROTEIN$, Stat1, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.	1
880	As siRNA, @COMPOUND$ induced IP-10, Stat1, @PROTEIN$, and Cox-2 and increased TLR3 mRNA expression.	1
881	As siRNA, @COMPOUND$ induced IP-10, @PROTEIN$, VCAM-1, and Cox-2 and increased TLR3 mRNA expression.	1
882	As siRNA, @COMPOUND$ induced IP-10, Stat1, VCAM-1, and Cox-2 and increased @PROTEIN$ mRNA expression.	1
883	As siRNA, @COMPOUND$ induced IP-10, Stat1, VCAM-1, and @PROTEIN$ and increased TLR3 mRNA expression.	1
884	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of @PROTEIN$ (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
885	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), @PROTEIN$ (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
886	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
887	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
888	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
889	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
890	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
891	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
892	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
893	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
894	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
895	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
896	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
897	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
898	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
899	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
900	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$ expression and PKC 0.05) in level in HC.	0
901	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$-alpha expression and PKC 0.05) in level in HC.	0
902	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
903	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
904	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
905	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
906	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
907	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
908	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
909	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
910	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
911	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
912	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
913	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated @PROTEIN$ and Tie2 in the SVZ compared with MCAo control.	1
914	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and @PROTEIN$ in the SVZ compared with MCAo control.	1
915	@COMPOUND$ significantly increased the expression of @PROTEIN$ and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
916	@COMPOUND$ significantly increased the expression of SDF1 and @PROTEIN$ in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
917	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1
918	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
919	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
920	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
921	Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1
922	C18 and C20Gb(3) were, in mixtures without @COMPOUND$ :1Gb(3), dominant negative for @PROTEIN$ vesicle binding.	0
923	@PROTEIN$/VT1bound C18 and @COMPOUND$ :1Gb(3) mixtures, although neither isoform bound alone.	1
924	Monolayer surface pressure measurement showed VT1, but not VT2, bound @COMPOUND$) at cellular DRM surface pressures, and confirmed loss of VT1 and @PROTEIN$ (but not VT2) specific C18Gb(3) binding.	0
925	@PROTEIN$ inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary @COMPOUND$.	0
926	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to @COMPOUND$ (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
927	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (@COMPOUND$) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
928	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary @COMPOUND$ (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
929	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with @PROTEIN$ (TGase) production and cell sporulation were investigated.	1
930	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with transglutaminase (@PROTEIN$) production and cell sporulation were investigated.	1
931	Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
932	Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
933	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), @PROTEIN$ (phox), and Nox4.	1
934	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like @PROTEIN$ (phox), p47 (phox), and Nox4.	1
935	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), p47 (phox), and @PROTEIN$.	1
936	We also demonstrated that the deletion of the @PROTEIN$ gene doubled ATP-driven @COMPOUND$ synthesis and increased cellular ATP synthetic activity.	1
937	Induction in the activity of @PROTEIN$ and azoreductase was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
938	Induction in the activity of lignin peroxidase and @PROTEIN$ was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
939	Inhibition of @PROTEIN$ kinase by @COMPOUND$ : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	1
940	The investigation included simulated docking experiments to fit @COMPOUND$ within the binding pocket of @PROTEIN$ followed by experimental in vitro and in vivo validations.	1
941	@COMPOUND$ was found to optimally fit within the binding pocket of @PROTEIN$ via several attractive interactions with key amino acids.	1
942	Pathological role of @PROTEIN$ on NKT cells in @COMPOUND$-mediated liver injury.	1
943	Methods: We injected @PROTEIN$ knock out (KO) or wild type mice with @COMPOUND$ (CCl(4)) and examined the difference of liver injury by immunological or histological analysis.	1
944	Effect of different @PROTEIN$ dosages on cell viability and @COMPOUND$ production by Kluyveromyces marxianus in SSF processes.	1
945	This study was aimed to study the effect of commercial @PROTEIN$ (Celluclast 1.5 LFG) on Kluyveromyces marxianus CECT 10875 growth and @COMPOUND$ production in SSF processes.	1
946	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-@COMPOUND$ to l-ornithine and urea.	1
947	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to l-ornithine and @COMPOUND$.	1
948	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to @COMPOUND$ and urea.	1
949	If no pretreatment applied, hydrolyses of the textiles by cellulase and @PROTEIN$ for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
950	If no pretreatment applied, hydrolyses of the textiles by @PROTEIN$ and beta-glucosidase for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
951	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
952	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
953	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to @COMPOUND$ or erlotinib.	1
954	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or @COMPOUND$.	1
955	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, @COMPOUND$, osteopontin, and @PROTEIN$ were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
956	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, @PROTEIN$, @COMPOUND$, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
957	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
958	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
959	The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
960	The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
961	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or @COMPOUND$ red (RuR).	0
962	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or @COMPOUND$ red (RuR).	0
963	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (@COMPOUND$).	0
964	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
965	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (@COMPOUND$).	0
966	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
967	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
968	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
969	Synaptic vesicle-bound @PROTEIN$ can support vesicular @COMPOUND$ uptake.	1
970	We present evidence that ATP generated by synaptic vesicle-associated @PROTEIN$ is harnessed to transport @COMPOUND$ into synaptic vesicles.	1
971	We examined the expression of @PROTEIN$ and ASCT1 in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
972	We examined the expression of Phgdh and @PROTEIN$ in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
973	Effect of @PROTEIN$ *3 genotype on the stereoselective pharmacokinetics of @COMPOUND$ in healthy subjects.	1
974	In conclusion, the present study showed that despite the evidence that @COMPOUND$ is stereoselectively metabolized, @PROTEIN$ *3 genotype did not affect stereoselective disposition of amlodipine.	0
975	It provides the evidence that @PROTEIN$ *3genotype plays a minor role in the interindividual variability of stereoselective disposition of @COMPOUND$ in humans.	1
976	Tissues were stained for BrdU, @PROTEIN$, vimentin, and @COMPOUND$ and eosin staining.	0
977	Tissues were stained for @COMPOUND$, @PROTEIN$, vimentin, and haematoxylin and eosin staining.	0
978	Tissues were stained for @COMPOUND$, Pax-7, @PROTEIN$, and haematoxylin and eosin staining.	0
979	Tissues were stained for BrdU, Pax-7, @PROTEIN$, and @COMPOUND$ and eosin staining.	0
980	In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1
981	Here, the @PROTEIN$-mediated (45)Ca(2+) uptake was compared in @COMPOUND$ (+)-loaded pig coronary artery smooth muscle and endothelial cells.	0
982	The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and @PROTEIN$ proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
983	The concept of a linkage between @PROTEIN$ and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
984	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (@PROTEIN$, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
985	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, @PROTEIN$, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
986	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (@PROTEIN$ and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
987	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) @PROTEIN$ in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
988	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and @PROTEIN$) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
989	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (@PROTEIN$) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
990	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon @PROTEIN$ (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
991	@COMPOUND$ (GSH), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
992	Glutathione (@COMPOUND$), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
993	Glutathione (GSH), catalase (@PROTEIN$), and @COMPOUND$ (MDA) activities in blood were measured.	0
994	Glutathione (@COMPOUND$), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
995	Glutathione (GSH), @PROTEIN$ (CAT), and @COMPOUND$ (MDA) activities in blood were measured.	0
996	@COMPOUND$ (GSH), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
997	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
998	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
999	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1000	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1001	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1002	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1003	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1004	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1005	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
1006	Effects of @COMPOUND$ ethyl ester on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0
1007	Effects of eicosapentaenoic acid @COMPOUND$ on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0
1008	Effects of eicosapentaenoic acid ethyl ester on @PROTEIN$ and @COMPOUND$ in lean and overweight (cafeteria diet-fed) rats.	0
1009	@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1
1010	@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1
1011	The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human @PROTEIN$ (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1012	The purpose of this study was to investigate bone @PROTEIN$ (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1013	The purpose of this study was to investigate bone morphogenetic protein (@PROTEIN$) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1014	@COMPOUND$, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of Cdk5/@PROTEIN$.	1
1015	@COMPOUND$, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of @PROTEIN$/p35.	1
1016	Certain non-steroidal anti-inflammatory drugs, e.g., the @PROTEIN$-specific nonsteroidal anti-inflammatory drugs, @COMPOUND$, raise Abeta(42) levels.	1
1017	This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, @COMPOUND$ production, @PROTEIN$ inhibition as well as reactive oxygen species generation.	0
1018	This was significantly in accordance with intracellular oxidative stress levels measured by glutathione depletion, malondialdehyde production, @PROTEIN$ inhibition as well as reactive @COMPOUND$ species generation.	0
1019	This was significantly in accordance with intracellular oxidative stress levels measured by @COMPOUND$ depletion, malondialdehyde production, @PROTEIN$ inhibition as well as reactive oxygen species generation.	0
1020	Catalepsy, serum @PROTEIN$, receptor binding profile and cortical (PFC), hippocampal (Hip) and @COMPOUND$ (DA) levels were determined.	0
1021	The characterization for the binding of calcium and @COMPOUND$ to Euplotes octocarinatus @PROTEIN$.	1
1022	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0
1023	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0
1024	We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1
1025	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0
1026	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0
1027	The objective of the present study was to investigate the effects of a high-@COMPOUND$ diet on @PROTEIN$ expression and IR localization and activity in the rat liver.	1
1028	Immobilization of @PROTEIN$ on the @COMPOUND$ modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	1
1029	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing @PROTEIN$ on the @COMPOUND$ modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	1
1030	At glutamatergic synapses, increased binding to the @COMPOUND$-B site located in the @PROTEIN$ (NMDAR) can enhance neurotransmission via NMDARs.	1
1031	The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum @COMPOUND$ and urine @PROTEIN$, and a temporary reduction of the creatinine clearance.	0
1032	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant @PROTEIN$ and over-expressed EGFR.	1
1033	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed @PROTEIN$.	1
1034	In vitro effect of radiation, antibody to @PROTEIN$ and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.	0
1035	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
1036	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
1037	@COMPOUND$ (CVF) is a structural and functional analog of @PROTEIN$ isolated from cobra venom.	1
1038	We therefore propose @COMPOUND$-dependent homodimerization to be an essential step in the regulation of @PROTEIN$-dependent transcription.	1
1039	The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0
1040	Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0
1041	Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0
1042	Thus, in keeping with the ability of neurosteroids to potentiate @COMPOUND$ currents via a broad variety of @PROTEIN$ isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.	1
1043	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. @COMPOUND$ plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1044	Furthermore, lysosomal integrity was disrupted after addition of @COMPOUND$ and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1045	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both @COMPOUND$ and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	0
1046	Imidazoline-induced amplification of glucose- and @COMPOUND$-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1047	Imidazoline-induced amplification of @COMPOUND$- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1048	@COMPOUND$-induced amplification of glucose- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1049	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1
1050	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1
1051	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
1052	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
1053	"Iron uptake by the ubiquitous iron-storage protein ferritin involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" @PROTEIN$ centre"" in individual subunits."	1
1054	"Iron uptake by the ubiquitous iron-storage protein @PROTEIN$ involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" ferroxidase centre"" in individual subunits."	1
1055	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
1056	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
1057	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
1058	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
1059	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, @COMPOUND$ consumption, @PROTEIN$ activity, and osteopontin.	0
1060	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0
1061	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0
1062	Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0
1063	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0
1064	We have investigated its antibacterial activity and binding activity to pathogenic whole cell antigens, @COMPOUND$ (LPS) and staphylococcal @PROTEIN$.	0
1065	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1066	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1067	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0
1068	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1069	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1070	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0
1071	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0
1072	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1073	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
1074	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0
1075	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and intimin (55.5%) genes were identified by @PROTEIN$.	0
1076	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and @PROTEIN$ (55.5%) genes were identified by PCR.	0
1077	@COMPOUND$, F41, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
1078	K99, @COMPOUND$, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
1079	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent @PROTEIN$ secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.	1
1080	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent insulin secretion, suppression of @PROTEIN$ secretion, slowing of gastric emptying, and reduction of food intake.	0
1081	@COMPOUND$ attenuates antigen-specific IgE production through the modulation of @PROTEIN$/Th2 balance in ovalbumin-sensitized BALB/c mice.	1
1082	BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or @COMPOUND$ (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with @PROTEIN$ (OVA).	0
1083	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1
1084	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1085	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1086	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
1087	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
1088	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1089	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
1090	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1091	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
1092	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
1093	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1094	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
1095	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1
1096	These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1
1097	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0
1098	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
1099	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
1100	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-methylene) triphosphate (@COMPOUND$).	1
1101	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-@COMPOUND$) triphosphate (AMPCPP).	1
1102	To identify the amino-acid residues that contribute to @PROTEIN$ activity, we prepared six mutants of SPS and examined their @COMPOUND$-dependent ATP consumption.	1
1103	"In @PROTEIN$. @COMPOUND$, the N-terminal loop, including the two residues, assumes different conformations (""open"" and ""closed"") between the two subunits."	1
1104	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of @PROTEIN$ or NPC2 proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
1105	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or @PROTEIN$ proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
1106	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished tryptophan) or @COMPOUND$ (NO) production.	0
1107	@PROTEIN$-diminished @COMPOUND$ and indolamine 2,3-dioxygenase-diminished tryptophan) or nitric oxide (NO) production.	1
1108	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished @COMPOUND$) or nitric oxide (NO) production.	0
1109	Memory impairment in young women at increased risk of depression: influence of @COMPOUND$ and 5-@PROTEIN$ genotype.	0
1110	The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to @COMPOUND$ secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-@PROTEIN$).	0
1111	The relative gene expression of @PROTEIN$ 0.05) in-@COMPOUND$ calves compared with+ Cu or-Cu+Mn calves.	1
1112	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0
1113	Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0
1114	We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0
1115	To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of @COMPOUND$ were evaluated on recombinant @PROTEIN$ expressed in HEK293T cells.	1
1116	Drosophila responds to detection of diamonopimelic-type microbial @COMPOUND$ through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory @PROTEIN$ pathway.	1
1117	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced @PROTEIN$ (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.	1
1118	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both @PROTEIN$ (+) and CD8(+) T cells.	1
1119	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
1120	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
1121	Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1
1122	The proteins identified belong to the photosynthesis, carbohydrate and @COMPOUND$ metabolism, and @PROTEIN$ functional categories.	0
1123	Electrospun polyglyconate (@COMPOUND$) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1
1124	Electrospun @COMPOUND$ (Maxon) and its blends with proteins such as gelatin and @PROTEIN$, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	1
1125	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
1126	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
1127	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
1128	Blood samples were collected to assay for biomarkers of oxidative stress (malondialdehyde and carbonyl groups) and antioxidants (@PROTEIN$, @COMPOUND$, alpha-tocopherol, and beta-carotene).	0
1129	Blood samples were collected to assay for biomarkers of oxidative stress (@COMPOUND$ and carbonyl groups) and antioxidants (@PROTEIN$, reduced glutathione, alpha-tocopherol, and beta-carotene).	0
1130	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
1131	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine @PROTEIN$ (@COMPOUND$-BSA).	1
1132	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (@COMPOUND$-@PROTEIN$).	1
1133	Low-density lipoprotein @COMPOUND$ and non-@PROTEIN$ cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	0
1134	Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein @COMPOUND$ (LDL-C) and non-@PROTEIN$ cholesterol (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	0
1135	Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0
1136	@PROTEIN$ blockade normalizes hippocampal alterations and cognitive impairment in @COMPOUND$-induced type 1 diabetes mice.	1
1137	Quantitative evaluation of @PROTEIN$ contribution to oral absorption of @COMPOUND$ in rats.	1
1138	@COMPOUND$ concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (@PROTEIN$) activities were determined.	1
1139	In brain tissue, Cu concentration, superoxide dismutase (@PROTEIN$) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
1140	In brain tissue, Cu concentration, @PROTEIN$ (SOD) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
1141	In brain tissue, @COMPOUND$ concentration, @PROTEIN$ (SOD) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
1142	In brain tissue, @COMPOUND$ concentration, superoxide dismutase (@PROTEIN$) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
1143	Na+/H+ exchanger isoform 3 (@PROTEIN$) is responsible for net uptake of @COMPOUND$ and water from the gastrointestinal (GI) tract.	1
1144	Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1
1145	The proliferation of the parental cell line was most efficiently stimulated by @COMPOUND$ (DHT), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0
1146	The proliferation of the parental cell line was most efficiently stimulated by 5alpha-dihydrotestosterone (@COMPOUND$), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0
1147	Levels of endothelial @PROTEIN$ and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus @COMPOUND$ levels.	0
1148	@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1149	Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1150	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM @COMPOUND$ but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm wortmannin.	1
1151	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM PD98059 but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm @COMPOUND$.	0
1152	In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0
1153	@PROTEIN$ expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with @COMPOUND$-based chemotherapy.	1
1154	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
1155	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
1156	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
1157	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
1158	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (@COMPOUND$, fluconazole and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
1159	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, @COMPOUND$ and itraconazole) by the reference method of the Clinical and Laboratory Standards Institute.	0
1160	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and @PROTEIN$) and antifungal drug sensitivity (amphotericin B, fluconazole and @COMPOUND$) by the reference method of the Clinical and Laboratory Standards Institute.	0
1161	As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1
1162	In this review we discuss the @PROTEIN$ that transport arsenic and @COMPOUND$ into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	1
1163	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy isoflavone @COMPOUND$-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	0
1164	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy @COMPOUND$ genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	1
1165	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine @PROTEIN$ (BSA).	1
1166	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (@PROTEIN$), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (BSA).	1
1167	Aqueous extract of cumin was tested for its antiglycating ability against @COMPOUND$-induced glycation of goat lens total soluble protein (TSP), alpha-crystallin from goat lens and a nonlenticular protein bovine serum albumin (@PROTEIN$).	1
1168	In hypersensitive alpha4L9'A mice, injections of a low dose of @COMPOUND$ (0.1 mg/kg) led to strong c-@PROTEIN$ expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	1
1169	"Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor @COMPOUND$ and complex Gbeta/Ggamma were identified as ""housekeeping"" molecules, through which all pathways of @PROTEIN$ network are cross-talking."	1
1170	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of @PROTEIN$ (SOD).	1
1171	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of superoxide dismutase (@PROTEIN$).	1
1172	This initiates a @COMPOUND$ signalling cascade resulting in the translocation of @PROTEIN$-bearing vesicles to the apical membrane.	1
1173	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (@PROTEIN$) and ATG12 proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1
1174	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and @PROTEIN$ proteins to their respective targets, @COMPOUND$ and the ATG5 protein.	1
1175	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (ATG8) and ATG12 proteins to their respective targets, @COMPOUND$ and the @PROTEIN$ protein.	0
1176	Levels of Atg transcripts and/or the @PROTEIN$-@COMPOUND$ adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.	1
1177	Studies have shown that administration of @COMPOUND$ (estrogen) after trauma-hemorrhage normalized cardiac @PROTEIN$ levels and restored cardiac functions under those conditions.	1
1178	Chemopreventive potential of @COMPOUND$ in mouse skin tumors through regulation of mitochondrial and @PROTEIN$/AKT signaling pathways.	1
1179	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1180	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1181	Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the @COMPOUND$-induced attenuation of serum IL-12 and @PROTEIN$.	0
1182	@PROTEIN$- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by @COMPOUND$.	1
1183	Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1
1184	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including @COMPOUND$ tolerance, @PROTEIN$ sensitivity and beta-cell function.	0
1185	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
1186	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
1187	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
1188	Aberrant methylation of the @PROTEIN$ (O6-methylguanine-DNA methyltransferase) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., @COMPOUND$) in malignant gliomas.	1
1189	Based on the preclinical evidence of @PROTEIN$ I (Topo-1) upregulation by @COMPOUND$ (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	1
1190	Mice lacking Niemann-Pick C1-Like 1 (@PROTEIN$) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and @COMPOUND$.	1
1191	In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0
1192	We found that mice lacking ABCG5/G8 and @PROTEIN$ (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
1193	We found that mice lacking @PROTEIN$/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
1194	In conclusion, @PROTEIN$ is essential for @COMPOUND$ to enter the body in mice.	1
1195	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
1196	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
1197	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
1198	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific @PROTEIN$ (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.	1
1199	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II @PROTEIN$ (Type-II RIPs, SNA-V), found in the same species.	0
1200	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II @PROTEIN$, SNA-V), found in the same species.	0
1201	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
1202	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
1203	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
1204	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
1205	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
1206	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
1207	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
1208	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
1209	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
1210	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1211	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
1212	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1213	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
1214	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1215	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1216	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1217	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1218	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of @PROTEIN$,but possibly by the glucocorticoid receptor (GR).	0
1219	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the @PROTEIN$ (GR).	1
1220	@COMPOUND$ drives @PROTEIN$ expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	1
1221	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
1222	The results obtained from the Fluo-3 image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the @COMPOUND$+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	1
1223	The results obtained from the @COMPOUND$ image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the Ca(2+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	0
1224	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1225	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1226	@COMPOUND$ is an effective chemo-sensitizer via @PROTEIN$ inhibition.	1
1227	@COMPOUND$ also recovered the depletion of I-kappaBalpha via @PROTEIN$ 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1228	@COMPOUND$ also recovered the depletion of @PROTEIN$ via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1229	Influence of @PROTEIN$ on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	0
1230	The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (@PROTEIN$) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	1
1231	Frozen-thawed semen samples (n=6) were washed in @COMPOUND$ and divided into two equal parts (control and @PROTEIN$ groups).	0
1232	@COMPOUND$ utilization was significantly higher in @PROTEIN$ 0.01) of incubation.	0
1233	Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0
1234	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, ERK and @PROTEIN$ (their activation was abrogated by the antioxidant @COMPOUND$).	1
1235	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways p38, @PROTEIN$ and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
1236	ROS activated almost immediately in a time- and concentration-dependent manner the @PROTEIN$ pathways p38, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
1237	ROS activated almost immediately in a time- and concentration-dependent manner the MAPK pathways @PROTEIN$, ERK and JNK (their activation was abrogated by the antioxidant @COMPOUND$).	1
1238	@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1
1239	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
1240	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
1241	Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0
1242	Effect of polyols on the solubility of bovine serum albumin (@PROTEIN$) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
1243	Effect of polyols on the solubility of bovine @PROTEIN$ (BSA) in the presence of @COMPOUND$ glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	0
1244	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
1245	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
1246	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1247	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1248	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1249	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1250	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1251	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1252	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1253	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1254	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1255	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1256	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1257	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1258	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1259	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1260	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1261	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1262	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1263	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1264	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1265	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1266	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1267	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1268	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1269	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1270	Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1271	Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1272	Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1
1273	@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1274	The enzyme responsible for D-@COMPOUND$ biosynthesis, @PROTEIN$ (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	1
1275	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with @COMPOUND$, or toluidine blue staining.	0
1276	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with propidium iodide, or @COMPOUND$ staining.	0
1277	However, @COMPOUND$ treatment resulted in intracellular accumulation of @PROTEIN$ and prevented its translocation to the cell surface.	1
1278	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and glyceraldehyde-3-phosphate dehydrogenase (@PROTEIN$) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
1279	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and @PROTEIN$ (G3PDH) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
1280	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated @PROTEIN$ activation in response to @COMPOUND$.	1
1281	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
1282	After serum @COMPOUND$ reached a stable nadir in the transplant recipients, @PROTEIN$ and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.	0
1283	It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0
1284	A study of rituximab and ifosfamide, carboplatin, and @COMPOUND$ chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1285	A study of rituximab and ifosfamide, @COMPOUND$, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1286	A study of rituximab and @COMPOUND$, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1287	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
1288	Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0
1289	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, @PROTEIN$ (CBG), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
1290	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, corticosteroid binding globulin (@PROTEIN$), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
1291	Total serum @COMPOUND$ and @PROTEIN$ were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	0
1292	The expressions of serotonin receptors (5-hydroxytryptamine receptor), corticotropin-releasing hormone (@PROTEIN$) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1293	The expressions of serotonin receptors (5-hydroxytryptamine receptor), @PROTEIN$ (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1294	The expressions of serotonin receptors (@PROTEIN$), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1295	The expressions of @PROTEIN$ (5-hydroxytryptamine receptor), corticotropin-releasing hormone (CRH) and @COMPOUND$ (AVP) mRNA in the hypothalamus were detected by real time PCR.	0
1296	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
1297	This mutation in the @PROTEIN$ gene replaces a @COMPOUND$ encoding codon with a stop signal.	1
1298	Augmentation of antibody responses by @COMPOUND$ and @PROTEIN$.	0
1299	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of @PROTEIN$, a known Hsp90 client protein.	1
1300	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of Chk1, a known @PROTEIN$ client protein.	0
1301	In addition, we observed a time- and dose-dependent decrease in @PROTEIN$ kinase level, a negative regulator of mitosis, after @COMPOUND$ treatment in gastrointestinal cancer cells.	1
1302	@PROTEIN$ alpha is a proximal mediator of synergistic hepatotoxicity from @COMPOUND$/lipopolysaccharide coexposure.	1
1303	Regulation of T-type @PROTEIN$.1 channels expression by synthetic glucocorticoid @COMPOUND$ in neonatal cardiac myocytes.	1
1304	These were mutated in onion @PROTEIN$ (acINV) according to the residue in festuca @COMPOUND$ : sucrose 1-fructosyltransferase (saSST) and vice versa.	0
1305	These were mutated in onion vacuolar invertase (acINV) according to the residue in festuca @COMPOUND$ : @PROTEIN$-fructosyltransferase (saSST) and vice versa.	0
1306	Optimization of chitosan succinate and chitosan @COMPOUND$ microspheres for oral delivery of @PROTEIN$ using response surface methodology.	0
1307	The relative pharmacological efficacy for chitosan @COMPOUND$ and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral @PROTEIN$ administration (4.68+/-1.52%).	0
1308	Furthermore, the effect of @COMPOUND$ on @PROTEIN$ has not been reported previously.	1
1309	In the present study, we investigated the cellular and molecular mechanisms of @PROTEIN$ regulation by @COMPOUND$ in VSMCs (vascular SMCs).	1
1310	@PROTEIN$-@COMPOUND$ (HDL-C) is invertedly related to the incidence of cardiovascular events.	1
1311	Effects of CYP2C19 and @PROTEIN$ genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
1312	Effects of @PROTEIN$ and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
1313	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
1314	Emerging evidence that both @PROTEIN$ (BDNF) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
1315	Emerging evidence that both brain-derived neurotrophic factor (@PROTEIN$) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
1316	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
1317	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1318	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1319	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1320	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
1321	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
1322	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1323	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
1324	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1325	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1326	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1
1327	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1
1328	Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by @COMPOUND$ expansion mutation in the @PROTEIN$ (AR).	1
1329	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1330	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1331	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1332	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
1333	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
1334	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
1335	In this study, we report a novel @PROTEIN$ defect in a Tunisian family, in which @COMPOUND$ 23 is substituted by a Stop codon causing a premature termination of translation.	1
1336	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
1337	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
1338	Effects of acceptor composition and mechanism of @PROTEIN$-mediated cellular free @COMPOUND$ efflux.	1
1339	Among the known mechanisms of reverse @COMPOUND$ transport (RCT), ATP binding cassette transporter G1 (@PROTEIN$)-mediated free cholesterol (FC) transport is the most recent and least studied.	1
1340	Here, we have characterized the efficiencies of different acceptors using baby hamster kidney (BHK) cells transfected with human @PROTEIN$ cDNA, which is inducible upon treatment with @COMPOUND$.	1
1341	@COMPOUND$ treatment significantly attenuated TNF-alpha, IL-6, and @PROTEIN$ 6 h after CLP.	1
1342	@COMPOUND$ treatment significantly attenuated TNF-alpha, @PROTEIN$, and IL-1beta 6 h after CLP.	1
1343	@COMPOUND$ treatment significantly attenuated @PROTEIN$, IL-6, and IL-1beta 6 h after CLP.	1
1344	The outer membrane @PROTEIN$ is involved in @COMPOUND$ tolerance and overproduction in Escherichia coli.	1
1345	Gene expression analysis revealed that the @PROTEIN$ gene encoding the outer membrane channel is essential for @COMPOUND$ tolerance in E. coli cells.	1
1346	Toll-like receptor (@PROTEIN$) 4 is a critical receptor and signal transducer for @COMPOUND$ (LPS), a major component of Gram-negative bacteria.	1
1347	Postprandial @COMPOUND$ and @PROTEIN$.05) in HTAG.	0
1348	@PROTEIN$ deficiency is a rare autosomal disorder of de novo @COMPOUND$ synthesis, which results in the accumulation of succinylpurines in body fluids.	1
1349	Both patients had an increased @COMPOUND$/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&gt;C; p.Met225Thr) in the exon 6 of the @PROTEIN$ gene.	1
1350	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
1351	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
1352	QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1
1353	QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1
1354	Inhibitory effects of Cefazolin and @COMPOUND$ on the activity of mushroom @PROTEIN$.	1
1355	Inhibitory effects of @COMPOUND$ and Cefodizime on the activity of mushroom @PROTEIN$.	1
1356	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
1357	Hepatic antioxidant status viz, @COMPOUND$ (GSH), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1358	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1359	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), @PROTEIN$ (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1360	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
1361	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), @PROTEIN$ (CAT 0.001).	0
1362	Hepatic antioxidant status viz, reduced glutathione (@COMPOUND$), @PROTEIN$ (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (CAT 0.001).	0
1363	Hepatic antioxidant status viz, @COMPOUND$ (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), quinone reductase (QR), catalase (@PROTEIN$ 0.001).	0
1364	Heme oxygenase-1 (@PROTEIN$) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
1365	@PROTEIN$ (HO-1) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
1366	A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, @PROTEIN$-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
1367	A shift toward proinflammatory microglial activation is indicated by the release of @PROTEIN$, tumor necrosis factor-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
1368	The human AU @PROTEIN$/enoyl-Coenzyme A hydratase (AUH) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the @COMPOUND$ degradation pathway.	1
1369	The human AU RNA binding protein/enoyl-Coenzyme A hydratase (@PROTEIN$) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the @COMPOUND$ degradation pathway.	1
1370	@PROTEIN$ is responsible for the sulfation and inactivation of @COMPOUND$ (E2) at physiological concentrations.	1
1371	The main mechanism of resistance to @COMPOUND$ was extra-chromosomal amplification of the @PROTEIN$ gene.	1
1372	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
1373	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-@PROTEIN$ (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
1374	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (@PROTEIN$ 12 h) has not been characterized.	0
1375	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (V@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
1376	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or @PROTEIN$-mediated mechanism.	0
1377	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an @PROTEIN$- and/or SR-BI-mediated mechanism.	0
1378	The @COMPOUND$-enhanced degradation of @PROTEIN$ involves both proteasomal and lysosomal activities.	1
1379	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1380	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1381	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
1382	Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1
1383	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
1384	@COMPOUND$ demonstrates potent inhibition of @PROTEIN$-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	1
1385	By using purified bovine @PROTEIN$, the reduction was observed in the presence of @COMPOUND$ (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.	1
1386	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1387	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
1388	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
1389	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
1390	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
1391	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1392	@COMPOUND$ (NO) and interlukin-6 (@PROTEIN$) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	0
1393	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
1394	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
1395	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
1396	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
1397	According to the oxidative stress concept, increased vascular @COMPOUND$ and peroxynitrite production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
1398	According to the oxidative stress concept, increased vascular superoxide and @COMPOUND$ production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
1399	mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
1400	mitochondrial @PROTEIN$ (ALDH-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
1401	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and @COMPOUND$.	0
1402	Finally, we will address the question whether @PROTEIN$-2 inactivation by @COMPOUND$ could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
1403	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical @COMPOUND$ tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
1404	Sex steroids enhance @PROTEIN$ and @COMPOUND$ oxidation in Chang liver cells.	0
1405	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
1406	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
1407	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
1408	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
1409	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
1410	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
1411	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, @COMPOUND$ (E) and lysine (K), at the solvent accessible site of @PROTEIN$.	1
1412	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, glutamic acid (E) and @COMPOUND$ (K), at the solvent accessible site of @PROTEIN$.	1
1413	Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (@PROTEIN$ and @COMPOUND$) influence platelet-mediated thrombosis.	0
1414	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and @PROTEIN$ (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1415	Furthermore, increased production of high inducible @PROTEIN$ (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1416	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (@PROTEIN$) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1417	Furthermore, increased production of high inducible nitric oxide synthase (@PROTEIN$) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1418	Functional inactivation of @PROTEIN$/@COMPOUND$ in human mesothelioma.	0
1419	The tumor suppressor @COMPOUND$ is encoded by the neurofibromatosis type 2 gene (@PROTEIN$) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	1
1420	@COMPOUND$-induced expression of the orphan nuclear receptor @PROTEIN$ in MA-10 Leydig cells involves a CaMKI pathway.	1
1421	@COMPOUND$-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a @PROTEIN$ pathway.	1
1422	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/@COMPOUND$ (cAMP) signaling pathway.	1
1423	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/cyclic adenosine monophosphate (@COMPOUND$) signaling pathway.	1
1424	Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1
1425	In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1
1426	Together, these results provide compelling evidence that @PROTEIN$ does not have a klotho-independent role in the regulation of systemic phosphate and @COMPOUND$ homeostasis.	0
1427	Based on fasting @PROTEIN$ and @COMPOUND$, several indices of insulin sensitivity have been developed in adults.	0
1428	Association of the @PROTEIN$ gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of @COMPOUND$ monotherapy in metastatic breast cancer patients.	1
1429	We evaluated the association between clinical outcome (safety and efficacy) of @COMPOUND$ monotherapy in metastatic breast cancer patients with @PROTEIN$ gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	1
1430	Activation of the Na+/K+-ATPase by @PROTEIN$ and @COMPOUND$ as a putative negative feedback mechanism in pancreatic beta-cells.	0
1431	Inhibiting @PROTEIN$ signalling in SUR1 (-/-) beta-cells blunted the @COMPOUND$-induced decrease of (Ca(2+))(c).	0
1432	In the mouse model of demyelination-remyelination induced by oral administration of @COMPOUND$, in situ hybridization showed an upregulation of the @PROTEIN$ gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	1
1433	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and @PROTEIN$) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
1434	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (@PROTEIN$), microglia (CD11b), or reactive glia (GFAP).	0
1435	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (@PROTEIN$).	0
1436	Cells positive for @PROTEIN$ mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	1
1437	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (@PROTEIN$), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
1438	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (@PROTEIN$, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
1439	These Ca2+-independent @PROTEIN$ display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains @COMPOUND$ functions.	0
1440	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-ERK 1/2 and phospho-@PROTEIN$ in the injured tissue.	1
1441	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-@PROTEIN$/2 and phospho-P38 in the injured tissue.	1
1442	The results of the present study show that @PROTEIN$ phosphorylation is unaltered by inflammation or @COMPOUND$ tolerance, each one individually, in the plantar tissue.	0
1443	In contrast, no significant differences in phospho-@PROTEIN$ expression were observed between naïve and tolerant animals acutely injected with saline or @COMPOUND$ in presence of CFA inflammation.	0
1444	These results suggest that @PROTEIN$ but not p38 could be implicated in the development of @COMPOUND$ tolerance during peripheral inflammation.	1
1445	Resistin, an adipokine-linked obesity with type 2 diabetes, impairs @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS) in beta-cells.	1
1446	In addition, @PROTEIN$ facilitates bi-directional flux of @COMPOUND$ by modifying the phospholipid content of the plasma membrane.	1
1447	Overall, @PROTEIN$ is the cell surface receptor responsible for selective uptake of lipoprotein @COMPOUND$ and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	1
1448	@PROTEIN$ kinase inhibition by @COMPOUND$ ameliorates diabetes-induced microvascular damage.	1
1449	Involvement of the @PROTEIN$/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of @COMPOUND$, a selective ROCK inhibitor, are investigated.	1
1450	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0
1451	This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
1452	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0
1453	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
1454	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
1455	The primary aims were to determine the effects of @PROTEIN$-4 inhibition on GLP-1 clearance and on hepatic @COMPOUND$ uptake.	0
1456	The primary aims were to determine the effects of DPP-4 inhibition on @PROTEIN$ clearance and on hepatic @COMPOUND$ uptake.	0
1457	@PROTEIN$ as an alternative to @COMPOUND$ in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	0
1458	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
1459	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
1460	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by @COMPOUND$, nor @PROTEIN$ positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	0
1461	Profile of serum @PROTEIN$ and IL-10 shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
1462	Profile of serum IL-1beta and @PROTEIN$ shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
1463	Cytochrome P450 (CYP) 1A1 and @PROTEIN$ are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
1464	Cytochrome P450 (@PROTEIN$) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
1465	@PROTEIN$ (CYP) 1A1 and CYP1B1 are inducible by @COMPOUND$ (dioxin) in the human breast cancer cell line, MCF-7.	1
1466	@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the @PROTEIN$ and CYP1B1 genes.	0
1467	@COMPOUND$ treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and @PROTEIN$ genes.	0
1468	@COMPOUND$ treatment leads to recruitment of the @PROTEIN$ to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes.	1
1469	These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of @PROTEIN$ than that of CYP1A1 and may be related to the more modest inducibility of the former.	1
1470	These results suggest that nucleosomal remodeling is less significant for @COMPOUND$-mediated induction of CYP1B1 than that of @PROTEIN$ and may be related to the more modest inducibility of the former.	1
1471	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human CYP1A1 and @PROTEIN$ genes in their natural chromosomal configurations.	1
1472	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human @PROTEIN$ and CYP1B1 genes in their natural chromosomal configurations.	1
1473	Following @COMPOUND$ there was a time-dependent redistribution of total @PROTEIN$ from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.	1
1474	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (@PROTEIN$) and serum total and free @COMPOUND$ levels are complex and often confusing to the physician.	1
1475	We further demonstrate that loss of @PROTEIN$ stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in Rho inhibition.	1
1476	We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, @PROTEIN$-mediated pathway that results in Rho inhibition.	1
1477	We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in @PROTEIN$ inhibition.	1
1478	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
1479	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
1480	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
1481	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1482	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
1483	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1484	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
1485	Both promoters are partially regulated by @COMPOUND$ via @PROTEIN$ and other RARs.	1
1486	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
1487	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (@PROTEIN$), but not by 100 nm BIM-23027, L-362855, or @COMPOUND$ ; agonists selective for the other four SSTRs known to exist in MIN6.	0
1488	A functional @PROTEIN$ system is essential for @COMPOUND$ antiobesity action.	1
1489	Transcription of @PROTEIN$ in the rodent ovary and placenta: alternative modes of @COMPOUND$ dependent and independent regulation.	1
1490	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage cytochrome P450 (@PROTEIN$) enzyme complex takes place in the inner mitochondrial membranes.	1
1491	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage @PROTEIN$ (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.	1
1492	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
1493	Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of @COMPOUND$ with apical ATP-binding cassette (ABC) @PROTEIN$.	1
1494	Furthermore, in Sf9-@PROTEIN$ membrane vesicles @COMPOUND$ inhibited transport of methotrexate in a concentration-dependent manner.	0
1495	Most cells contain @COMPOUND$ sulfoxide reductases, which catalyze a @PROTEIN$-dependent reduction of methionine sulfoxide back to methionine.	1
1496	The intracellular free methionine and @COMPOUND$ pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
1497	The intracellular free @COMPOUND$ and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
1498	Activity of muscle citrate synthase and @PROTEIN$, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0
1499	Activity of muscle @PROTEIN$ and 3-hydroxyacyl-CoA dehydrogenase, as well as maximal @COMPOUND$ uptake and 10-km performance time, remained unaltered in both groups.	0
1500	Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1
1501	In control rats, @COMPOUND$, @PROTEIN$ and MS significantly enhanced the HFV response.	0
1502	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and @COMPOUND$.	0
1503	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas @COMPOUND$ lowered the peak HFV response to MS and H2O2.	0
1504	@COMPOUND$ injection and MS elicited significant and similar increases in isoprostanes and @PROTEIN$.	1
1505	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, @COMPOUND$ for fever, C-reactive protein (@PROTEIN$), and total and percent gammadeltaT-cells.	0
1506	@PROTEIN$ (17beta-HSD1) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1
1507	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1
1508	The combination of @COMPOUND$-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the @PROTEIN$ neurotrophin receptor protein.	1
1509	Given the significant biological roles of @PROTEIN$ and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the @COMPOUND$-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	0
1510	Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
1511	Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
1512	TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0
1513	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, phosphate, and urine specific gravity, but higher @PROTEIN$ and @COMPOUND$ concentrations than hyperthyroid cats.	0
1514	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher @PROTEIN$ and creatinine concentrations than hyperthyroid cats.	0
1515	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher lipase and creatinine concentrations than hyperthyroid cats.	0
1516	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, phosphate, and urine specific gravity, but higher lipase and @COMPOUND$ concentrations than hyperthyroid cats.	0
1517	A role for @PROTEIN$ receptors in @COMPOUND$ signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	1
1518	2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0
1519	Serum testosterone, estradiol, sex hormone binding globulin (@PROTEIN$), and @COMPOUND$ levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
1520	Serum testosterone, @COMPOUND$, sex hormone binding globulin (@PROTEIN$), and dehydroepiandrosterone levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
1521	Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-@COMPOUND$, LDL-cholesterol and @PROTEIN$ sensitivity (p=0.009 and p=0.002, respectively).	0
1522	Preprandial concentrations of glucose, @PROTEIN$, @COMPOUND$, and IGF-I fluctuated over time without significant treatment effect.	0
1523	Preprandial concentrations of @COMPOUND$, NEFA, lactate, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
1524	Preprandial concentrations of glucose, NEFA, @COMPOUND$, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
1525	Preprandial concentrations of @COMPOUND$, @PROTEIN$, lactate, and IGF-I fluctuated over time without significant treatment effect.	0
1526	In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0
1527	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
1528	Domain shape annealing is observed from branched to rounded shapes after @PROTEIN$ activity quenching by @COMPOUND$, with a decay halftime of approximately 10 min.	0
1529	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor @COMPOUND$ (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
1530	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor @COMPOUND$ (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
1531	@PROTEIN$ receptors are membrane cation channels gated by extracellular @COMPOUND$.	1
1532	At 1 min before the exposure rats were treated with one of the following: intravenous @PROTEIN$, 4.4 mg/kg; intraperitoneal (ip) @COMPOUND$, 25mg/kg; or ip trolox, 500 microg/kg.	0
1533	At 1 min before the exposure rats were treated with one of the following: intravenous @PROTEIN$, 4.4 mg/kg; intraperitoneal (ip) ilomastat, 25mg/kg; or ip @COMPOUND$, 500 microg/kg.	0
1534	Treatment with @PROTEIN$ or @COMPOUND$ eliminated these PF changes, yielding results comparable with controls for each of these parameters.	0
1535	While @PROTEIN$ and @COMPOUND$ both alleviated the PF perturbations, surprisingly only aprotinin reduced the observed pathology, both grossly and histologically.	0
1536	These early results indicate that treatment with @PROTEIN$ and to a lesser extent @COMPOUND$ reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	0
1537	@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0
1538	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
1539	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
1540	@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1
1541	@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
1542	Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
1543	Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
1544	@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
1545	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of @PROTEIN$, NO efflux and @COMPOUND$ concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	0
1546	In this study, we describe the crystal structure of yeast @PROTEIN$ in complex with @COMPOUND$ (chitobiose).	1
1547	Mutagenesis studies confirm the critical role of the @COMPOUND$-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for @PROTEIN$ activity.	1
1548	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
1549	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
1550	The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1
1551	The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1
1552	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
1553	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
1554	Currently, @COMPOUND$ (PLP)-dependent @PROTEIN$ (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	1
1555	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
1556	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces @PROTEIN$-stimulated PKB activation and @COMPOUND$ uptake.	0
1557	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces insulin-stimulated @PROTEIN$ activation and @COMPOUND$ uptake.	0
1558	In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular @PROTEIN$ of LN229 cells exceeded that of the previous designed lead compound @COMPOUND$.	1
1559	Modulation of Rac1 activity by @COMPOUND$/@PROTEIN$ regulates pulmonary endothelial barrier function.	0
1560	Modulation of @PROTEIN$ activity by @COMPOUND$/DDAH regulates pulmonary endothelial barrier function.	1
1561	Requirement of @PROTEIN$ for antidepressive efficiency of @COMPOUND$ : implication in adult hippocampal neurogenesis.	1
1562	Collectively, these findings suggest that @PROTEIN$ is required for the antidepressive action of @COMPOUND$ via regulating adult hippocampal neurogenesis.	1
1563	However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1
1564	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0
1565	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0
1566	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0
1567	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0
1568	Plasma levels of @COMPOUND$, cortisol, and @PROTEIN$ were measured.	0
1569	Plasma levels of citalopram, @COMPOUND$, and @PROTEIN$ were measured.	0
1570	An increase in @COMPOUND$ and @PROTEIN$ concentrations was observed from the EOI until 60 min after the EOI.	0
1571	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
1572	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
1573	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
1574	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
1575	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
1576	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0
1577	We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0
1578	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1
1579	Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1
1580	To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with @COMPOUND$, and then @PROTEIN$ was immobilized on the coated electrode.	0
1581	To prevent the effects of interfering anionic species, such as @COMPOUND$ and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
1582	To prevent the effects of interfering anionic species, such as uric acid and @COMPOUND$, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
1583	A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
1584	A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
1585	Osteoblasts up-regulate the expression of extracellular @PROTEIN$ following attachment to @COMPOUND$).	1
1586	Pharmacological stimulation of @PROTEIN$ channels with @COMPOUND$ (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	1
1587	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (@COMPOUND$).	1
1588	Consistently, the totality of striatal neurons responded to @COMPOUND$ (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).	1
1589	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator @COMPOUND$ (PMA).	1
1590	The effects of capsaicin and of @COMPOUND$ were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
1591	The effects of @COMPOUND$ and of PMA were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
1592	Finally, we provided evidence for @COMPOUND$ as an endovanilloid substance in the striatum, since genetic inhibition of anandamide degradation resulted in a tonic activation of @PROTEIN$ channels modulating glutamate but not GABA release.	1
1593	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for @PROTEIN$, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
1594	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated @PROTEIN$ secretion in pancreatic beta-cells.	1
1595	Regulatory roles for @PROTEIN$, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
1596	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a @PROTEIN$, in @COMPOUND$-stimulated insulin secretion (GSIS).	0
1597	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a small G-protein, in @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS).	1
1598	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for @PROTEIN$, a small G-protein, in @COMPOUND$-stimulated insulin secretion (GSIS).	0
1599	@COMPOUND$-bound form) and membrane association of @PROTEIN$ in INS 832/13 cells and rat islets.	0
1600	Interestingly, however, in contrast to the inhibitory effects of @COMPOUND$, @PROTEIN$ gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.	0
1601	A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
1602	A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
1603	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1
1604	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1
1605	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
1606	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
1607	We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-@PROTEIN$-mediated @COMPOUND$ efflux.	1
1608	Liver @COMPOUND$ DNA adducts and acrylamide and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
1609	Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal @COMPOUND$ @PROTEIN$ adducts were also determined.	1
1610	Liver glycidamide DNA adducts and @COMPOUND$ and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
1611	Molecular and biochemical characterization of a distinct @PROTEIN$ involved in @COMPOUND$ production from Aeromonas media.	1
1612	TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0
1613	TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0
1614	@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0
1615	TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0
1616	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1
1617	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1
1618	EDTA or glutathione notably inhibited the enzymatic activities of @PROTEIN$, whereas @COMPOUND$ and SDS activated them.	1
1619	These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1
1620	These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1
1621	Age-associated impairment of @PROTEIN$ phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and PP2A.	1
1622	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, @PROTEIN$, and PP2A.	1
1623	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through @PROTEIN$, PTEN, and PP2A.	1
1624	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and @PROTEIN$.	1
1625	NADH/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (@PROTEIN$--&gt; @COMPOUND$+ NAD (+).	1
1626	NADH/NAD (+) ratio can be normalized by the activation or overexpression of @PROTEIN$ (NNT--&gt; @COMPOUND$+ NAD (+).	1
1627	@COMPOUND$/NAD (+) ratio can be normalized by the activation or overexpression of nicotinamide nucleotide transhydrogenase (@PROTEIN$--&gt; NADPH+ NAD (+).	1
1628	@COMPOUND$/NAD (+) ratio can be normalized by the activation or overexpression of @PROTEIN$ (NNT--&gt; NADPH+ NAD (+).	1
1629	These results indicate that cloned embryos have aberrant DNA methylation in the @COMPOUND$ sites of the PE region of @PROTEIN$, and this may contribute directly to abnormal expression of this gene in cloned embryos.	1
1630	Xenopus follicle-enclosed oocytes are endowed with @PROTEIN$ located in the follicular cell membrane ; their stimulation by @COMPOUND$ elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).	1
1631	Here we show the first direct quantitative evidence for @PROTEIN$ binding to the cap analog @COMPOUND$.	1
1632	van't Hoff analysis of @COMPOUND$-@PROTEIN$ equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.	1
1633	eIFiso4G was shown to enhance the interaction of @PROTEIN$ with @COMPOUND$ cap analog by 2.4-fold.	1
1634	@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1
1635	Mutations known to confer resistance to @COMPOUND$ (@PROTEIN$ C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.	1
1636	Mutations known to confer resistance to @COMPOUND$ (NS5B C316Y) and boceprevir (@PROTEIN$ V170A) were present in the combination-resistant replicons.	0
1637	@COMPOUND$ is a pesticide whose acute toxicity is due to inhibition of @PROTEIN$.	1
1638	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1639	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1640	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1641	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
1642	Elucidation of the human @PROTEIN$ (HSA) binding site for the Cu-PTSM and @COMPOUND$ radiopharmaceuticals.	1
1643	Elucidation of the human @PROTEIN$ (HSA) binding site for the @COMPOUND$ and Cu-ATSM radiopharmaceuticals.	1
1644	Elucidation of the human serum albumin (@PROTEIN$) binding site for the @COMPOUND$ and Cu-ATSM radiopharmaceuticals.	1
1645	Elucidation of the human serum albumin (@PROTEIN$) binding site for the Cu-PTSM and @COMPOUND$ radiopharmaceuticals.	1
1646	This study examines the structural basis for @PROTEIN$ binding of @COMPOUND$ and Cu-ATSM via competition with drugs having known albumin binding sites.	1
1647	This study examines the structural basis for @PROTEIN$ binding of Cu-PTSM and @COMPOUND$ via competition with drugs having known albumin binding sites.	1
1648	@COMPOUND$ from @PROTEIN$.	1
1649	At 8:1 warfarin: @PROTEIN$ @COMPOUND$ levels increased 300-500%.	1
1650	@COMPOUND$ was observed except at high ibuprofen: @PROTEIN$ ratios, where secondary ibuprofen binding to the IIA site may cause modest radiopharmaceutical displacement.	0
1651	Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in @COMPOUND$ phosphorylation of @PROTEIN$ (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	1
1652	A significant decrease was observed in GABA (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1
1653	A significant decrease was observed in GABA (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	0
1654	A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
1655	A significant decrease was observed in GABA (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1
1656	A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
1657	A significant decrease was observed in @COMPOUND$ (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
1658	Interaction of @PROTEIN$ and @COMPOUND$ in endemic dilated cardiomyopathy.	1
1659	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in @PROTEIN$ (GPx-1) gene.	1
1660	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in glutathione peroxidase-1 (@PROTEIN$) gene.	1
1661	However, under the pressure of a death stimulus such as @COMPOUND$ treatment, L. infantum @PROTEIN$ is released from the single mitochondrion and translocates to the nucleus, where it is thought to participate in the process of DNA degradation that is associated with programmed cell death.	1
1662	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
1663	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
1664	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
1665	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
1666	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
1667	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
1668	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
1669	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased @PROTEIN$ @COMPOUND$ (HDL-C) and reduced atherogenic index in normotensive rats.	1
1670	This analysis reveals @PROTEIN$ as major and unsuspected gates of @COMPOUND$+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	1
1671	@PROTEIN$ is an important neuronal calcium sensor (NCS) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
1672	Recoverin is an important neuronal calcium sensor (@PROTEIN$) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
1673	A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1
1674	Acylcarnitines have been suggested to play a role in @PROTEIN$ resistance, as well as other @COMPOUND$ metabolites.	0
1675	In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with @COMPOUND$/fat oxidation and @PROTEIN$ sensitivity in lean healthy humans.	0
1676	@COMPOUND$ binding to human @PROTEIN$ : a study of protein conformation and binding affinity.	1
1677	Glucocorticoid-activated GR repressed @PROTEIN$ gene induction by @COMPOUND$ (LPS).	1
